European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Cite this article
Importance of differential diagnosis post-treatment of adenocarcinoma of the uterine cervix: a case report of sarcoidosis
S. Oliveira Calil de Paula1,2,*, M.C. de Assis Brito Alves1, J.O. de Almeida Falcão Junior1, C.L. Soares Laranjeira1, M. Salvador Géo Géo1
1 Department of Obstetrics and Gynecology, Mater Dei Hospital, Belo Horizonte, Minas Gerais, Brazil
2 Department of Oncology, Mater Dei Hospital, Belo Horizonte, Minas Gerais, Brazil
Eur. J. Gynaecol. Oncol. 2016, 37(5), 714–716; https://doi.org/10.12892/ejgo3059.2016
Published: 10 October 2016
Objective: To report a case of sarcoidosis post-treatment of adenocarcinoma of the uterine cervix. Case: A 38-year-old, G1P1A0 was admitted to the present hospital for palliative treatment of Stage IB1 adenocarcinoma of the uterine cervix with hepatic recurrence posthysterectomy. The patient initially received six cycles of cisplatin and taxol leading to complete remission. Six months after the palliative treatment, MRI revealed slight changes in the pelvis, suggestive of the involvement of the left iliac lymph node. Anatomo-pathological results after lymphadenectomy showed tumor recurrence. Following additional pelvic radiotherapy, the patient remained asymptomatic. However, oncologic control performed three months later exposed mediastinal lymphadenopathy and new biopsy revealed sarcoidosis. The patient remained asymptomatic in the subsequent follow-ups without evidences of tumor recurrence. This study shows the importance of differential diagnosis during the oncologic monitoring of cervical cancer patients to avoid unnecessary treatments at the expense of better therapeutic options.
Adenocarcinoma of the uterine cervix